Search Results - "De Waart, D. Rudi"
-
1
Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport
Published in Hepatology (Baltimore, Md.) (01-07-2006)“…Progressive familial intrahepatic cholestasis type 1 (PFIC1, Byler disease, OMIM 211600) is a severe inherited liver disease caused by mutations in ATP8B1…”
Get full text
Journal Article -
2
ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity
Published in Hepatology (Baltimore, Md.) (01-01-2008)“…Mutations in ATP8B1 cause progressive familial intrahepatic cholestasis type 1 and benign recurrent intrahepatic cholestasis type 1. Previously, we have shown…”
Get full text
Journal Article -
3
Stable Overexpression of the Constitutive Androstane Receptor Reduces the Requirement for Culture with Dimethyl Sulfoxide for High Drug Metabolism in HepaRG Cells
Published in Drug metabolism and disposition (01-01-2017)“…Dimethylsulfoxide (DMSO) induces cellular differentiation and expression of drug metabolic enzymes in the human liver cell line HepaRG; however, DMSO also…”
Get full text
Journal Article -
4
Activity of the Bile Salt Export Pump (ABCB11) Is Critically Dependent on Canalicular Membrane Cholesterol Content
Published in The Journal of biological chemistry (10-04-2009)“…Mutations in ATP8B1 cause severe inherited liver disease. The disease is characterized by impaired biliary bile salt excretion (cholestasis), but the mechanism…”
Get full text
Journal Article -
5
The lipid flippase heterodimer ATP8B1–CDC50A is essential for surface expression of the apical sodium-dependent bile acid transporter (SLC10A2/ASBT) in intestinal Caco-2 cells
Published in Biochimica et biophysica acta (01-12-2014)“…Deficiency of the phospholipid flippase ATPase, aminophospholipid transporter, class I, type 8B, member 1 (ATP8B1) causes progressive familial intrahepatic…”
Get full text
Journal Article -
6
Differential and organ-specific functions of organic solute transporter α and β in experimental cholestasis
Published in JHEP reports (01-05-2022)“…Organic solute transporter (OST) subunits OSTα and OSTβ facilitate bile acid efflux from the enterocyte into the portal circulation. Patients with deficiency…”
Get full text
Journal Article -
7
Glutamine Synthetase in Muscle Is Required for Glutamine Production during Fasting and Extrahepatic Ammonia Detoxification
Published in The Journal of biological chemistry (26-03-2010)“…The main endogenous source of glutamine is de novo synthesis in striated muscle via the enzyme glutamine synthetase (GS). The mice in which GS is selectively…”
Get full text
Journal Article -
8
Intestinal Farnesoid X Receptor Activation by Pharmacologic Inhibition of the Organic Solute Transporter α-β
Published in Cellular and molecular gastroenterology and hepatology (01-01-2018)“…Background & Aims The organic solute transporter α-β (OSTα-OSTβ) mainly facilitates transport of bile acids across the basolateral membrane of ileal…”
Get full text
Journal Article -
9
Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis
Published in Liver international (01-09-2016)“…Background & Aims To better understand the pathogenesis of primary sclerosing cholangitis, anti‐ and pro‐inflammatory factors were studied in bile. Methods…”
Get full text
Journal Article -
10
Glutamine synthetase deficiency in murine astrocytes results in neonatal death
Published in Glia (15-04-2010)“…Glutamine synthetase (GS) is a key enzyme in the “glutamine‐glutamate cycle” between astrocytes and neurons, but its function in vivo was thus far tested only…”
Get full text
Journal Article -
11
Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge
Published in Hepatology international (01-01-2017)“…Background Bile salts likely contribute to liver injury in patients with primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC). Fibroblast…”
Get full text
Journal Article -
12
Ezetimibe: A biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemia
Published in Biochimica et biophysica acta (01-08-2012)“…As recently demonstrated in patients with factor IX deficiency, adeno‐associated virus (AAV)-mediated liver-directed therapy is a viable option for inherited…”
Get full text
Journal Article -
13
Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats
Published in Molecular pharmacology (01-05-2001)“…MRP2 is an apical transporter expressed in hepatocytes and the epithelial cells of the small intestine and kidney proximal tubule. It extrudes organic anions,…”
Get more information
Journal Article -
14
FXR agonism protects against liver injury in a rat model of intestinal failure-associated liver disease
Published in Journal of clinical and translational research (15-01-2018)Get full text
Journal Article -
15
Lack of UGT1 Isoforms in Gunn Rats Changes Metabolic Ratio and Facilitates Excretion of the Food-Derived Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
Published in Toxicology and applied pharmacology (15-01-2001)“…UDP-glucuronosyltransferases (UGTs) play an important role in detoxification of endo- and xenobiotics. Deficiencies of these enzymes can have serious…”
Get full text
Journal Article -
16
FXR agonism protects against liver injury in a rat model of intestinal failure-associated liver disease
Published in Journal of clinical and translational research (15-01-2018)“…Intestinal failure-associated liver disease (IFALD) is a clinical challenge. The pathophysiol-ogy is multifactorial and remains poorly understood. Disturbed…”
Get full text
Journal Article -
17
Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides
Published in Journal of hepatology (01-04-2006)“…Multidrug Resistance Protein 3 (MRP3) transports bile salts and glucuronide conjugates in vitro and is postulated to protect the liver in cholestasis. Whether…”
Get full text
Journal Article -
18
Mrp2-deficiency in the rat impairs biliary and intestinal excretion and influences metabolism and disposition of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)
Published in Carcinogenesis (New York) (01-05-2001)“…While metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), the most abundant food-derived heterocyclic amine and carcinogen, has been studied…”
Get full text
Journal Article